0 NASDAQ Companies - November 16, 2018Teligent, Inc. Receives Notification of Deficiency From NASDAQ Related to the Delayed Filing of Form 10-QBUENA, N.J., Nov. 16, 2018 (GLOBE NEWSWIRE) — Teligent, Inc. (NASDAQ: TLGT), on November 13, 2018 received a standard notice […]Read More
0 NASDAQ Companies - November 16, 2018Ecology and Environment, Inc. Receives Nasdaq NoticeLANCASTER, N.Y., Nov. 16, 2018 (GLOBE NEWSWIRE) — On October 26, 2018, Ecology and Environment, Inc. (Nasdaq: EEI) (E & […]Read More
0 TSX News - November 16, 2018TransGlobe Energy Corporation Announces Update to Significant ShareholderAIM & TSX: “TGL” & NASDAQ: “TGA” CALGARY, Alberta, Nov. 16, 2018 (GLOBE NEWSWIRE) — TR-1: Standard form for notification […]Read More
0 TSX News - November 16, 2018Colabor Group Announces a Rationalization PlanBOUCHERVILLE, Quebec, Nov. 16, 2018 (GLOBE NEWSWIRE) — Colabor Group Inc. (TSX: GCL) (“Colabor” or the “Company”) today announces a […]Read More
0 TSX Venture News - November 16, 2018Crown Point Announces Operating and Financial Results for the Three and Nine Months Ended September 30, 2018CALGARY, Alberta, Nov. 16, 2018 (GLOBE NEWSWIRE) — (TSX-V:CWV): Crown Point Energy Inc. (“Crown Point”, the “Company” or “we”) today […]Read More
0 TSX Venture News - November 16, 2018Gen III Oil Corp. Closes First Tranche of Non-Brokered Private PlacementNot for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, British Columbia, Nov. 16, […]Read More
0 TSX Venture News - November 16, 2018Appulse Corporation: Reporting results for the Nine Months ended September 30, 2018CALGARY, Alberta, Nov. 16, 2018 (GLOBE NEWSWIRE) — Appulse Corporation (“Appulse”) today reported a net income of $138,000 for the […]Read More
0 NYSE Companies - November 16, 2018Equus Announces Third Quarter Net Asset ValueHOUSTON, Nov. 16, 2018 (GLOBE NEWSWIRE) — Equus Total Return, Inc. (NYSE: EQS) (the “Fund” or “Equus”) reports net assets […]Read More
0 NYSE Companies - November 16, 2018FDA approves Novartis drug Promacta® for first-line SAA and grants Breakthrough Therapy designation for additional new indicationPromacta receives FDA approval for first-line treatment of severe aplastic anemia (SAA) and Breakthrough Therapy designation for low platelet counts […]Read More
0 NASDAQ Companies - November 16, 2018Univar and Nexeo Solutions Announce Expiration of Hart-Scott-Rodino Waiting PeriodDOWNERS GROVE, Ill. and THE WOODLANDS, Texas, Nov. 16, 2018 (GLOBE NEWSWIRE) — Univar Inc. (NYSE: UNVR) (“Univar”) and Nexeo […]Read More